Movement Alert｜Vertex Pharmaceuticals Rises 3.12% in Regular Trading, Trading at $465.745

Market Focus06-23

On June 23, Vertex Pharmaceuticals rose 3.12% in regular trading, trading at $465.745/share, with Turnover of $330 million.

Within the Biotechnology sector where Vertex Pharmaceuticals belongs, individual stocks showed divergent performance. Among individual stocks, Apogee Therapeutics up 46.72%, AbbVie up 6.92%, Gilead Sciences up 1.08%, Regeneron Pharmaceuticals down 0.17%, Moderna, Inc. down 6.1%.

Vertex Pharmaceuticals Incorporated is a global biotechnology company committed to scientific innovation, having developed approved therapies for cystic fibrosis, sickle cell disease, transfusion-dependent beta thalassemia, and acute pain, while advancing next-generation clinical programs in areas including IgA nephropathy and Type 1 diabetes.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1182247234?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-06-23 02:22","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1182247234","market":"us","top_or_hot":-1,"title":"Movement Alert｜Vertex Pharmaceuticals Rises 3.12% in Regular Trading, Trading at $465.745","media":"Market Focus","content":"<p><p>On June 23, Vertex Pharmaceuticals rose 3.12% in regular trading, trading at $465.745/share, with Turnover of $330 million.</p><p>Within the Biotechnology sector where Vertex Pharmaceuticals belongs, individual stocks showed divergent performance. Among individual stocks, Apogee Therapeutics up 46.72%, AbbVie up 6.92%, Gilead Sciences up 1.08%, Regeneron Pharmaceuticals down 0.17%, Moderna, Inc. down 6.1%.</p><p>Vertex Pharmaceuticals Incorporated is a global biotechnology company committed to scientific innovation, having developed approved therapies for cystic fibrosis, sickle cell disease, transfusion-dependent beta thalassemia, and acute pain, while advancing next-generation clinical programs in areas including IgA nephropathy and Type 1 diabetes.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Movement Alert｜Vertex Pharmaceuticals Rises 3.12% in Regular Trading, Trading at $465.745</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMovement Alert｜Vertex Pharmaceuticals Rises 3.12% in Regular Trading, Trading at $465.745\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1054767329\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Market Focus </p>\n<p class=\"h-time\">2026-06-23 02:22</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p><p>On June 23, Vertex Pharmaceuticals rose 3.12% in regular trading, trading at $465.745/share, with Turnover of $330 million.</p><p>Within the Biotechnology sector where Vertex Pharmaceuticals belongs, individual stocks showed divergent performance. Among individual stocks, Apogee Therapeutics up 46.72%, AbbVie up 6.92%, Gilead Sciences up 1.08%, Regeneron Pharmaceuticals down 0.17%, Moderna, Inc. down 6.1%.</p><p>Vertex Pharmaceuticals Incorporated is a global biotechnology company committed to scientific innovation, having developed approved therapies for cystic fibrosis, sickle cell disease, transfusion-dependent beta thalassemia, and acute pain, while advancing next-generation clinical programs in areas including IgA nephropathy and Type 1 diabetes.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"VRTX","symbol_name":"福泰制药","start_time":0,"source_url":"","article_id":"1182247234","we_media_id":"1054767329","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1182247234","pubTimestamp":1782152559,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Market Focus","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1054767329","head_image":"https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a"},"summary":"On June 23, Vertex Pharmaceuticals rose 3.12% in regular trading, trading at $465.745/share, with Turnover of $330 million.Within the Biotechnology sector where Vertex Pharmaceuticals belongs,...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"VRTX":"福泰制药"},"translate_title":"走势提示|Vertex Pharmaceuticals常规交易上涨3.12%，报465.745美元","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"VRTX":1},"content_text":"On June 23, Vertex Pharmaceuticals rose 3.12% in regular trading, trading at $465.745/share, with Turnover of $330 million.Within the Biotechnology sector where Vertex Pharmaceuticals belongs, individual stocks showed divergent performance. Among individual stocks, Apogee Therapeutics up 46.72%, AbbVie up 6.92%, Gilead Sciences up 1.08%, Regeneron Pharmaceuticals down 0.17%, Moderna, Inc. down 6.1%.Vertex Pharmaceuticals Incorporated is a global biotechnology company committed to scientific innovation, having developed approved therapies for cystic fibrosis, sickle cell disease, transfusion-dependent beta thalassemia, and acute pain, while advancing next-generation clinical programs in areas including IgA nephropathy and Type 1 diabetes.(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.44.0","shortVersion":"4.44.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1182247234","isCrawlerRequest":true}